Clinical Trial Update: Study Using CP-461 to Treat Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating CP-461 for advanced prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CP-461

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED